Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rawan Ranna, Burcu Uner, Neslihan Ustundag Okur & Cetin Tas. (2023) Improvement of dissolution profile of eplerenone with solidified self-emulsifying drug delivery systems (S-SEDDS). Drug Development and Industrial Pharmacy 49:4, pages 305-315.
Read now
Read now
Yingxi Zhang, Xiaoxiao Du, Hanxun Wang, Zhonggui He & Hongzhuo Liu. (2021) Sacubitril-valsartan cocrystal revisited: role of polymer excipients in the formulation. Expert Opinion on Drug Delivery 18:4, pages 515-526.
Read now
Read now
Marwah Aljohani, Patrick McArdle & Andrea Erxleben. (2021) Dual-drug amorphous formulation of gliclazide. Drug Development and Industrial Pharmacy 47:2, pages 302-307.
Read now
Read now
Articles from other publishers (19)
Bruno Ekawa, Hermínio P. Diogo, Ricardo A. E. Castro, Flávio J. Caires & M. Ermelinda S. Eusébio. (2023) Coamorphous Systems of Valsartan: Thermal Analysis Contribution to Evaluate Intermolecular Interactions Effects on the Structural Relaxation. Molecules 28:17, pages 6240.
Crossref
Crossref
Abbas Akhgari, Fatemeh Nosrati, Pouria Rahmanian-Devin, Farzin Hadizadeh, Hossein Shahdadi Sardou & Hossein Kamali. (2022) Enhancement of Valsartan Dissolution Rate by the Increased Porosity of Pellets Using Supercritical CO2: Optimization via Central Composite Design. Journal of Pharmaceutical Innovation.
Crossref
Crossref
Iára Cristina Schmücker Lenschow, Giovana Carolina Bazzo, Melissa Zétola, Hellen Karine Stulzer, Luciano Soares & Bianca Ramos Pezzini. (2022) Ball-milled valsartan and its combination with mannitol: the case of drug polyamorphism. Journal of Thermal Analysis and Calorimetry 147:16, pages 8765-8777.
Crossref
Crossref
Ka̅rlis Be̅rziņš, Sara J. Fraser-Miller, Thomas Rades & Keith C. Gordon. (2022) Low-Frequency Raman Spectroscopy as an Avenue to Determine the Transition Temperature of β- and γ-Relaxation in Pharmaceutical Glasses. Analytical Chemistry 94:23, pages 8241-8248.
Crossref
Crossref
Cristina Prieto, Zoran Evtoski, María Pardo-Figuerez, Julia Hrakovsky & Jose M. Lagaron. (2021) Nanostructured Valsartan Microparticles with Enhanced Bioavailability Produced by High-Throughput Electrohydrodynamic Room-Temperature Atomization. Molecular Pharmaceutics 18:8, pages 2947-2958.
Crossref
Crossref
A.P.C. Siqueira, E.Y. Ionashiro, G. Bannach, A.R. De Souza, N.H. Morgon, M.A. Soares, A.B. Siqueira & M.I.G. Leles. (2021) Spectroscopy and thermal studies of valsartan compounds with metals Mn(II), Fe(II), Co(II), Ni(II), Cu(II) and Zn(II) in the solid state. Thermochimica Acta 698, pages 178892.
Crossref
Crossref
Stoja Milovanovic, Jelena Djuris, Aleksandra Dapčević, Marija Lucic Skoric, Djordje Medarevic, Stefan M. Pavlović & Svetlana Ibric. (2021) Preparation of floating polymer-valsartan delivery systems using supercritical CO2. Journal of Polymer Research 28:3.
Crossref
Crossref
Yingxi Zhang, Yuan Gao, Xiaoxiao Du, Rou Guan, Zhonggui He & Hongzhuo Liu. (2020) Combining Co-Amorphous-Based Spray Drying with Inert Carriers to Achieve Improved Bioavailability and Excellent Downstream Manufacturability. Pharmaceutics 12:11, pages 1063.
Crossref
Crossref
F. MUHANA, R. ABU-HUWAIJ, N. KHALAF, F. KHALILI & N. SHALAN. (2020) Synthesis and Characterization of Mesoporous Silica Carrier Releasing Valsartan. Asian Journal of Chemistry 32:11, pages 2927-2933.
Crossref
Crossref
Agnieszka Snela, Barbara Jadach, Anna Froelich, Marcin Skotnicki, Kasylda Milczewska, Monika Rojewska, Adam Voelkel, Krystyna Prochaska & Janina Lulek. (2019) Self-emulsifying drug delivery systems with atorvastatin adsorbed on solid carriers: formulation and in vitro drug release studies. Colloids and Surfaces A: Physicochemical and Engineering Aspects 577, pages 281-290.
Crossref
Crossref
Djordje Medarević, Sandra Cvijić, Vladimir Dobričić, Miodrag Mitrić, Jelena Djuriš & Svetlana Ibrić. (2018) Assessing the potential of solid dispersions to improve dissolution rate and bioavailability of valsartan: In vitro-in silico approach. European Journal of Pharmaceutical Sciences 124, pages 188-198.
Crossref
Crossref
Bruno Ekawa, Wilhan Donizete Gonçalves Nunes, José Augusto Teixeira, Marco Aurélio Cebim, Elias Yuki Ionashiro & Flávio Junior Caires. (2018) New complexes of light lanthanides with the valsartan in the solid state: Thermal and spectroscopic studies. Journal of Analytical and Applied Pyrolysis 135, pages 299-309.
Crossref
Crossref
Yannick Guinet, Laurent Paccou, Florence Danède, Patrick Derollez & Alain Hédoux. (2017) Structural description of the marketed form of valsartan: A crystalline mesophase characterized by nanocrystals and conformational disorder. International Journal of Pharmaceutics 526:1-2, pages 209-216.
Crossref
Crossref
Joaquim J. Moura Ramos & Hermínio P. Diogo. (2017) Thermal behavior and molecular mobility in the glassy state of three anti-hypertensive pharmaceutical ingredients. RSC Advances 7:18, pages 10831-10840.
Crossref
Crossref
Shrawan Baghel, Helen Cathcart & Niall J. O'Reilly. (2016) Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs. Journal of Pharmaceutical Sciences 105:9, pages 2527-2544.
Crossref
Crossref
Marcin Skotnicki, David C. Apperley, Juan A. Aguilar, Bartłomiej Milanowski, Marek Pyda & Paul Hodgkinson. (2015) Characterization of Two Distinct Amorphous Forms of Valsartan by Solid-State NMR. Molecular Pharmaceutics 13:1, pages 211-222.
Crossref
Crossref
Marcin Skotnicki, Juan A. Aguilar, Marek Pyda & Paul Hodgkinson. (2014) Bisoprolol and Bisoprolol-Valsartan Compatibility Studied by Differential Scanning Calorimetry, Nuclear Magnetic Resonance and X-Ray Powder Diffractometry. Pharmaceutical Research 32:2, pages 414-429.
Crossref
Crossref
Febry Ardiana, Suciati & Gunawan Indrayanto. 2015.
431
493
.
Qiuping Ma, Hongrui Sun, Erxi Che, Xin Zheng, Tongying Jiang, Changshan Sun & Siling Wang. (2013) Uniform nano-sized valsartan for dissolution and bioavailability enhancement: Influence of particle size and crystalline state. International Journal of Pharmaceutics 441:1-2, pages 75-81.
Crossref
Crossref